Sarli L, Costi R, Gobbi S, Sansebastiano G, Roncoroni L
The Department of Surgery, Institute of General Surgery and Surgical Therapy, Parma University School of Medicine, Italy.
Eur J Gastroenterol Hepatol. 2000 Nov;12(11):1175-80.
Routine use of endoscopic retrograde cholangiography (ERC) and/or intravenous cholangiography (IVC) or magnetic resonance cholangiopancreatography (MRCP) before laparoscopic cholecystectomy (LC) is not cost-effective. The objective of this study was to determine precise and easily applicable criteria to select patients who should undergo IVC, MRCP and/or ERC before LC.
Prospectively collected data from 74 consecutive patients who were diagnosed with asymptomatic common bile duct stones (CBDS) before undergoing LC, were compared with data from 74 matched controls without CBDS. Using the chi2 test, those variables were identified which were significantly related to the presence of CBDS. These were inserted into a logistic multiple regression model and, by means of conditional regression analysis, each variable was assigned a score from -2 to +4 proportional to the odds ratio. By adding up the scores obtained, a classification was made as to high, medium and low CBDS risk.
As a result, 51 patients were found to be low-risk cases, 53 medium-risk and 44 high-risk. Assuming no further assessment of the bile duct needed to be carried out in low-risk patients, an IVC or MRCP in those at medium risk and an ERC in those at high risk, a calculation was made of the positive predictive value and the sensitivity of the system proposed. The positive predictive value and the sensitivity of the procedure were calculated as being greater than 90%.
This predictive system for the risk of CBDS allows the selective use of ERC, IVC and MRCP to ensure a high yield and improve cost-effectiveness. A controlled prospective study will verify these results.
在腹腔镜胆囊切除术(LC)前常规使用内镜逆行胆管造影(ERC)和/或静脉胆管造影(IVC)或磁共振胰胆管造影(MRCP)不具有成本效益。本研究的目的是确定精确且易于应用的标准,以选择在LC前应接受IVC、MRCP和/或ERC的患者。
前瞻性收集74例连续接受LC前被诊断为无症状胆总管结石(CBDS)患者的数据,并与74例匹配的无CBDS对照患者的数据进行比较。使用卡方检验,确定那些与CBDS存在显著相关的变量。将这些变量纳入逻辑多元回归模型,并通过条件回归分析,根据比值比为每个变量分配从-2到+4的分数。通过将获得的分数相加,对CBDS风险进行高、中、低分类。
结果发现,51例患者为低风险病例,53例为中风险,44例为高风险。假设低风险患者无需进一步评估胆管,中风险患者进行IVC或MRCP,高风险患者进行ERC,计算所提出系统的阳性预测值和敏感性。该程序的阳性预测值和敏感性计算结果均大于90%。
这种CBDS风险预测系统允许选择性使用ERC、IVC和MRCP,以确保高检出率并提高成本效益。一项对照前瞻性研究将验证这些结果。